---
schema_version: "secwatch.filing_event.v1"
accession: "0001551986-23-000024"
form_type: "8-K"
ticker: null
cik: "0001551986"
company_name: "9 METERS BIOPHARMA, INC."
filed_at: "2023-04-06T23:59:59+00:00"
generated_at: "2026-06-17T05:08:07.091739+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# 9 Meters Biopharma receives Nasdaq deficiency notice for low equity; faces note default

## Summary
- March 31, 2023 Nasdaq letter for non-compliance with Rule 5550(b)(1) requiring $2.5M minimum stockholders' equity.
- Reported stockholders' equity of $2,400,543 in Form 10-K for period ended December 31, 2023.
- Non-compliance triggers default under $4,949,522 convertible note; holder can demand 115% of principal.
- Company negotiating waiver; no immediate acceleration expected from the institutional investor.
- Company has 45 days to submit compliance plan; if accepted, up to 180-day extension to regain compliance.

## SEC filing metadata
- accession: 0001551986-23-000024
- form_type: 8-K
- cik: 0001551986
- company_name: 9 METERS BIOPHARMA, INC.
- filed_at: 2023-04-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551986/000155198623000024/0001551986-23-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551986/000155198623000024/nmtr-20230331.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001551986-23-000024
- JSON: https://secwatch.observer/filing/0001551986-23-000024.json
- Plain text: https://secwatch.observer/filing/0001551986-23-000024.txt

## Key facts
- Listing & Compliance Notices
  9 METERS BIOPHARMA, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: March 31, 2023, the Company received a letter from Nasdaq indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Stock Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In its annual report on Form 10-K for the period ended December 31, 2023, the Company reported stockholders’ equity of $2,400,543, and, as a result, does not currently satisfy Listing Rule 5550(b)(1). Nasdaq’s letter has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551986/000155198623000024/0001551986-23-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.